The MarketWatch News Department was not involved in the creation of this content.-- New research advances genetic diagnosis -- Demonstrates the potential to expand equitable acces ...

New research advances genetic diagnosisDemonstrates the potential to expand equitable access to treatment for patients living with rare inherited metabolic and neurodegenerative diseasesBALTIMORE ...

GeneDx Holdings WGS announced a sponsored genetic testing program with Zevra Therapeutics to improve diagnosis for patients suspected of having Niemann-Pick Disease Type C (NPC), a rare and ...

Scientists say that 55 percent of differences in human lifespan are due to genetic makeup, much more than previously believed ...

The study will be conducted as a multiregional clinical trial at sites in the US and additional countries.

Roche Receives CE Mark For First IVD Immunoassay Blood Test To Identify Carriers Of Apoe4, A Genetic Variant Present In Up To 60% Of Patients Diagnosed With Alzheimer's Disease. The Elecsys ApoE4 ...

A closer examination of the APOL1 gene in Black patients with kidney disease can provide more accurate diagnoses than current protocols, a new study from researchers at Columbia University Vagelos ...

The test can help assess your lifetime risk for cardiovascular disease. That, along with earlier treatment for high cholesterol, is part of new doctors' guidelines.

Heart health experts released new guidance to help identify early risk factors for heart disease that go beyond tracking ...

The 2026 ACC/AHA dyslipidemia guidelines emphasize earlier cholesterol screening from age 19, improved risk prediction using ...

Opus Genetics, Inc. (NASDAQ:IRD) is among the 11 Fastest Growing Penny Stocks to Buy Right Now. On March 2, 2026, BTIG raised ...

Germline testing can identify hereditary cancer, which leads to implications for family members, cascade testing for relatives, and starting surveillance and prevention measures: Genetic testing in ...